全文获取类型
收费全文 | 848篇 |
免费 | 62篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 46篇 |
妇产科学 | 15篇 |
基础医学 | 124篇 |
口腔科学 | 40篇 |
临床医学 | 67篇 |
内科学 | 170篇 |
皮肤病学 | 38篇 |
神经病学 | 93篇 |
特种医学 | 103篇 |
外科学 | 62篇 |
综合类 | 27篇 |
预防医学 | 33篇 |
眼科学 | 24篇 |
药学 | 38篇 |
中国医学 | 1篇 |
肿瘤学 | 26篇 |
出版年
2023年 | 16篇 |
2021年 | 7篇 |
2019年 | 6篇 |
2018年 | 5篇 |
2017年 | 9篇 |
2016年 | 6篇 |
2015年 | 10篇 |
2014年 | 20篇 |
2013年 | 30篇 |
2012年 | 14篇 |
2011年 | 14篇 |
2010年 | 29篇 |
2009年 | 28篇 |
2008年 | 22篇 |
2007年 | 18篇 |
2006年 | 32篇 |
2005年 | 21篇 |
2004年 | 19篇 |
2003年 | 30篇 |
2002年 | 20篇 |
2001年 | 22篇 |
2000年 | 8篇 |
1999年 | 20篇 |
1998年 | 27篇 |
1997年 | 46篇 |
1996年 | 36篇 |
1995年 | 31篇 |
1994年 | 30篇 |
1993年 | 26篇 |
1992年 | 29篇 |
1991年 | 17篇 |
1990年 | 19篇 |
1989年 | 36篇 |
1988年 | 23篇 |
1987年 | 26篇 |
1986年 | 36篇 |
1985年 | 23篇 |
1984年 | 8篇 |
1983年 | 5篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1979年 | 4篇 |
1978年 | 6篇 |
1977年 | 12篇 |
1976年 | 6篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1969年 | 6篇 |
1967年 | 4篇 |
排序方式: 共有910条查询结果,搜索用时 15 毫秒
901.
902.
Hussain Jaafari Lesley A. Houghton Robert M. West Anurag Agrawal Imran Aziz Christopher J. Black Maura Corsetti Farag Shuweihdi Maria Eugenicos Peter A. Paine Alexander C. Ford Peter J. Whorwell Shrikant I. Bangdiwala Olafur S. Palsson Ami D. Sperber Dipesh H. Vasant 《Neurogastroenterology and motility》2023,35(6):e14574
Background
There are minimal epidemiological data comparing the burden of disorders of gut brain interaction (DGBI) in the UK with other countries. We compared the prevalence of DGBI in the UK with other countries that participated in the Rome Foundation Global Epidemiology Study (RFGES) online.Methods
Participants from 26 countries completed the RFGES survey online including the Rome IV diagnostic questionnaire and an in-depth supplemental questionnaire with questions about dietary habits. UK sociodemographic and prevalence data were compared with the other 25 countries pooled together.Key Results
The proportion of participants with at least one DGBI was lower in UK participants compared with in the other 25 countries (37.6% 95% CI 35.5%–39.7% vs. 41.2%; 95% CI 40.8%–41.6%, p = 0.001). The UK prevalence of 14 of 22 Rome IV DGBI, including irritable bowel syndrome (4.3%) and functional dyspepsia (6.8%), was similar to the other countries. Fecal incontinence, opioid-induced constipation, chronic nausea and vomiting, and cannabinoid hyperemesis (p < 0.05) were more prevalent in the UK. Cyclic vomiting, functional constipation, unspecified functional bowel disorder, and proctalgia fugax (p < 0.05) were more prevalent in the other 25 countries. Diet in the UK population consisted of higher consumption of meat and milk (p < 0.001), and lower consumption of rice, fruit, eggs, tofu, pasta, vegetables/legumes, and fish (p < 0.001).Conclusions and Inferences
The prevalence and burden of DGBI is consistently high in the UK and in the rest of the world. Opioid prescribing, cultural, dietary, and lifestyle factors may contribute to differences in the prevalence of some DGBI between the UK and other countries. 相似文献903.
904.
905.
906.
907.
Simon R. Knowles Pragalathan Apputhurai Olafur S. Palsson Shrikant Bangdiwala Ami D. Sperber Antonina Mikocka-Walus 《Neurogastroenterology and motility》2023,35(6):e14594
Background
The Rome Foundation Global Epidemiology Study on the disorders of gut–brain interaction (DGBI) was used to assess the national prevalence of all 22 DGBI, the percentage of respondents meeting diagnostic criteria for at least one DGBI, and the rates of comorbid anxiety, depression, and somatization in Australia and 25 other countries.Methods
The survey was conducted in Australia and 25 other countries through the Internet and included the Rome IV Diagnostic Questionnaire and an in-depth supplemental questionnaire.Key Results
Two thousand thirty-six Australian adults completed the survey nationwide: mean age 47.34 ± 17.00 years, 50.15% males. Overall, 38.67% of Australians met criteria for at least one DGBI, with unspecified functional bowel disorder (8.01%) and then functional constipation (7.71%) being the most prevalent. For those Australians with at least one DGBI, rates of anxiety, depression, and somatization where high (26.58%, 28.96%, and 63.10%, respectively), with functional chest pain having the highest rates of anxiety (55.00%) and depression (57.50%), and irritable bowel syndrome (mixed) having the highest somatization rate (75.86%). The odds of having a DGBI increased with greater anxiety (OR: 1.09, CI 95%: 0.97, 1.23), depression (OR: 1.17, CI 95%: 1.04, 1.32), and somatization (OR: 1.17, CI 95%: 1.14, 1.20) symptom severity.Conclusions and Inferences
The current study represents the most comprehensive epidemiological exploration of DGBI and mental health in Australia to date, including their prevalence and distributions across sex and age, associations between DGBI and anxiety, depression, and somatization. The findings warrants future comparisons between population characteristics and health care systems differences in order to reduce the burden of DGBI and mental illness worldwide. 相似文献908.
909.